Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus

Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus

US Patent 10434169 · Granted Oct 8, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Display device2025
Method and apparatus for managing operation data of appliance for failure predic2025
Adeno-associated virus variant capsids and methods of use thereof2025
Organic light-emitting devices2025
Pharmaceutical composition for preventing or treating nonalcoholic fatty liver d2024
Water purifier2024
Thioredoxin 1 epitope, encoding nucleic acid and methods of binding a monoclonal2024
Hyper-parameter optimization method for spiking neural network and the processin2024
Method and apparatus for managing operation data of appliance for failure predic2024
Compound for organic electronic element, organic electronic element using the sa2024
Preparation method of polyalkylene carbonate2024
Compound for organic electronic element, organic electronic element using the sa2023